Search filters

List of works by Michael Thomas

A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study Protocol

scientific article published on 14 October 2020

A mighty oak in the rapidly expanding field of checkpoint inhibition for NSCLC.

scientific article published on March 2017

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

scientific article published on 15 February 2019

A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer

scientific article published on 06 March 2017

AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients

scientific article published on 02 January 2017

Abstract 3374: Large-scale single-cell whole transcriptomic analyses reveal distinct malignant phenotypes of CTCs from NSCLC patients

scientific article published in 2022

Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinib

scientific article published on 10 September 2014

Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy

scientific article published on 24 September 2011

Assessment of thymidylate synthase expression in biopsy specimens and corresponding resection specimens of non‐small‐cell lung cancer ⬇️

scientific article published on March 28, 2012

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

scientific article published on 02 November 2020

Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Stage NSCLC With High Programmed Death-Ligand 1 Expression

scientific article published in 2022

CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer.

scientific article published on 22 September 2017

COX-2 upregulation in thymomas and thymic carcinomas

scientific article published on 01 November 2006

Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer

scientific article published on 01 September 2020

Characteristics and outcome of patients with second primary lung cancer ⬇️

scientific article published on October 11, 2012

Characteristics of lung cancer after a previous malignancy

Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP): A prospective German registry in stage IV NSCLC AIO-TRK-0315

scientific article

Clinical value of CT-based preoperative software assisted lung lobe volumetry for predicting postoperative pulmonary function after lung surgery

Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy ⬇️

scientific article published on November 10, 2011

Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer.

scientific article published in July 2013

Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer

scientific article published on 01 April 2009

Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life

scientific article published in April 2004

Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases

scientific article published on 19 February 2019

Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity‐modulated RT radiotherapy and cetuximab ⬇️

scientific article published on January 24, 2011

Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study

scientific article

Comparison of two ERCC1 antibodies as prognostic and predictive biomarkers for early non-small cell lung cancer

scientific article published in July 2014

Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer-Cross-Sectional Study of Eligibility and Administration Rates

scientific article published on 01 December 2020

Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma

scientific article published on 01 April 2021

Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients

scientific article published in May 2008

Corrigendum to “Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)” [Lung Cancer 152 (2021) 174–184]

scientific article

Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer ⬇️

scientific article published on February 21, 2013

Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer

scientific article published on 17 June 2020

Deficient CD247 expression is a typical histopathological characteristic of thymomas with cortical features

scientific article published on 16 October 2018

Defining molecular risk in ALK NSCLC

scientific article published on 03 May 2019

Depression, anxiety and disease-related distress in couples affected by advanced lung cancer

scientific article

Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival

scientific article published on 21 January 2019

Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial

scientific article published on 22 April 2020

EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.

scientific article published on 29 August 2013

EML4-ALK V3, treatment resistance, and survival: refining the diagnosis of ALK+ NSCLC

scientific article published on 01 June 2018

EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ NSCLC.

scientific article

Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer

scientific article published on 24 June 2008

Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations

scientific article published in 2021

Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer

scientific article published on 18 March 2015

Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib

scientific article

Expression and mutation analysis of EGFR, c-KIT, and β-catenin in pulmonary blastoma ⬇️

scientific article published on February 3, 2011

Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas

scientific article published on 22 July 2020

Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices

scientific article published on 15 December 2017

Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long non-coding RNA PLUT - an exploratory study

scientific article published on 06 April 2020

Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation Studies

scientific article published on 18 December 2020

Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC

article

Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma

scientific article published on 04 October 2016

Glycodelin: A New Biomarker with Immunomodulatory Functions in Non-Small Cell Lung Cancer

scientific article

HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy

scientific article published on 13 December 2004

Identification of a highly lethal V3+ TP53+ subset in ALK+ lung adenocarcinoma

scientific article published on 30 October 2018

Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer.

scientific article

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy

scientific article published on 30 November 2018

Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians

scientific article published on 01 December 2018

Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial

scientific article

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

scientific article

KRAS-Mutation Positive, Metastatic Tonsil Carcinoma With Cancer Stem-Like Cell Features and Long-Term Response to Gefitinib: A Case Report and Review of the Literature ⬇️

scientific article published on 09 May 2011

Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance

scientific article published on 6 March 2018

Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA

scientific article published on 05 November 2020

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients

scientific article

MINI01.20: Interim Quality of Life (QoL) Results from ABOUND.sqm: nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Topic: Medical Oncology

scientific article

Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer Subtypes

scientific article published on 21 September 2020

Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels

scientific article published on 04 February 2019

Molecular determinants of response to RTK-targeting agents in nonsmall cell lung cancer

scientific article

Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany: First results from the prospective German Registry CRISP (AIO-TRK-0315)

scientific article

Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

scientific article published on 19 September 2016

Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas

scientific article published on 21 August 2006

Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial

scientific article published on 18 September 2020

Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial

article

Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case report

scientific article

Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer

scientific article published on 02 December 2016

Non-small-cell lung cancer: multimodality approach in stage-III resectable disease

scientific article

Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages

scientific article published on 12 April 2020

Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors

scientific article published on 23 April 2020

Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy

scientific article

Outcome and prognostic factors in single brain metastases from small-cell lung cancer

scientific article published on 30 October 2017

Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas

scientific article

Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).

scientific article published on 25 November 2015

Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation

scientific article published on 14 September 2016

Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients

scientific article published on 01 March 2020

Pain Management in Palliative Care

scientific article published on 15 May 2017

Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells.

scientific article published on September 2007

Pathways regulating the expression of the immunomodulatory protein glycodelin in non‑small cell lung cancer

article

Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer ⬇️

scientific article published on December 1, 2010

Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat

scientific article published on 22 November 2020

Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker

scientific article published on 20 January 2015

Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer

scientific article

Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer

scientific article published in December 2004

Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer

scientific article published on 25 October 2006

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors

scientific article published on 05 October 2020

Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement

scientific article published on 01 February 2020

Safety and Efficacy of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors Using a Risk-optimized Fractionation Scheme

scientific article published on 18 November 2020

Safety and efficacy of buparlisib (BKM120) and chemotherapy in advanced, squamous non-small cell lung cancer (sqNSCLC): Results from the phase Ib/II BASALT-2 and BASALT-3 studies

Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers

scientific article published in March 2002

Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer

scientific article published on 13 December 2019

Signal transduction pathways as novel therapy targets in lung cancer

scientific article

Size matters: Dissecting key parameters for panel-based tumor mutational burden analysis

scientific article published on 04 December 2018

Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts

scientific article published on 23 July 2019

Structures and ways of decision making in thoracic oncology: foreword

scientific article published in January 2013

Surgical intervention for pulmonary metastases

scientific article

Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma

scientific article published on 17 October 2016

Targeting rare and non-canonical driver variants in NSCLC – An uncharted clinical field

scientific article published on 21 February 2021

Targeting the epidermal growth factor receptor in non-small cell lung cancer

scientific article published on 26 November 2010

The European initiative for quality management in lung cancer care.

scientific article published on 23 March 2014

The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC

scientific article published on 01 January 2019

The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival ⬇️

scientific article published on March 5, 2012

The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP) ⬇️

scientific article published on April 7, 2012

Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).

scientific article published in January 2016

Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients.

scientific article published on 18 December 2013

Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol

scientific article (publication date: 8 May 2007)

Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis

scientific article

Variant classification in precision oncology

scientific article published on 21 May 2019

Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial

scientific article published on 16 July 2018

[Clinic for Radiation Therapy and Internal Medicine Oncology, Pius-Hospital Oldenburg, Germany]

scientific article published on 13 May 2011

[Foreword]

scientific article published on 01 January 2008

[Local and systemic therapy of non-small cell lung carcinoma (NSCLC)]

scientific article published on 14 May 2010

[Therapy in non-small-cell lung carcinoma (NSCLC) in local advanced stage (inoperable IIIA/IIIB)]

scientific article published on 06 September 2006

[Thoracic oncology - optimization through integrated approaches, quality assurance, and molecular biology. Forward]

scientific article published on 15 May 2012

Paulina is supported by:

About Paulina

Help